European Journal of Internal Medicine
Volume 21, Issue 4 , Pages 310-314, August 2010

Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study

  • M. Assem

      Affiliations

    • Hepatology Department, National Liver Institute, Sheben Al koom, Egypt
    • Corresponding Author InformationCorresponding author. Department of hepatology and gastroenterology, National Liver Institute, Menofyia University, Sheben Al koom, Egypt. Tel.: +20 105109581; fax: +20 482222743.
    • ,
  • G. El Azab

      Affiliations

    • Hepatology Department, National Liver Institute, Sheben Al koom, Egypt
    • ,
  • M. Abdel Rasheed

      Affiliations

    • Internal Medicine Department, Al Noor hospital, Makkah, Saudi Arabia
    • ,
  • M. Abdelfatah

      Affiliations

    • Internal Medicine Department, Al Ammed polyclinic, Al kharj, Saudi Arabia
    • ,
  • M. Shastery

      Affiliations

    • Clinical Pathology Department, Al Ammed polyclinic, Al kharj, Saudi Arabia

Received 5 April 2010; received in revised form 17 May 2010; accepted 19 May 2010. published online 17 June 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0953-6205(10)00104-4

doi:10.1016/j.ejim.2010.05.011

European Journal of Internal Medicine
Volume 21, Issue 4 , Pages 310-314, August 2010

Article Tools

* Image Usage & Resolution